SCHEMBL6498752

SCHEMBL6498752

CCOC(=O)c1ccc(-c2cc(C)c3nc(C)n(Cc4ncc(C(F)(F)F)cc4Cl)c3c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
MAPT P10636 2/20 0.41
ALDH1A1 P00352 3/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
PDK2 Q15119 1/20 0.38
HPGD P15428 1/20 0.38
KDM4E B2RXH2 1/20 0.38
DCTPP1 Q9H773 1/20 0.38
MAOB P27338 1/20 0.37
RECQL P46063 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PDGFRB P09619 1/20 0.36
PDGFRA P16234 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6490617 0.90 DCTPP1 (0.43) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL6487814 0.90 MEN1 (0.43) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL6490408 0.89 JMJD6 (0.41) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL6490031 0.85 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL6488927 0.82 MRGPRX4 (0.44) MEN1KMT2AMAPTPOLBGAA
SCHEMBL6489573 0.82 MAOB (0.39) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL6489988 0.81 DCTPP1 (0.40) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL6499428 0.81 SYK (0.42) MEN1KMT2AALDH1A1L3MBTL1CYP2C19
SCHEMBL6488962 0.80 MRGPRX4 (0.41) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL7199966 0.79 CYP1A2 (0.38) MEN1KMT2AMAPTALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD MEN1 1604/4885KMT2A 561/4885MAPT 3168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.